首页> 美国卫生研究院文献>The Journal of Biological Chemistry >Surfactant protein A down-regulates epidermal growth factor receptor by mechanisms different from those of surfactant protein D
【2h】

Surfactant protein A down-regulates epidermal growth factor receptor by mechanisms different from those of surfactant protein D

机译:表面活性剂蛋白A通过不同于表面活性剂蛋白D的机制下调表皮生长因子受体

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

We recently reported that the lectin surfactant protein D (SP-D) suppresses epidermal growth factor receptor (EGFR) signaling by interfering with ligand binding to EGFR through an interaction between the carbohydrate-recognition domain (CRD) of SP-D and N-glycans of EGFR. Here, we report that surfactant protein A (SP-A) also suppresses EGF signaling in A549 human lung adenocarcinoma cells and in CHOK1 cells stably expressing human EGFR and that SP-A inhibits the proliferation and motility of the A549 cells. Results with 125I-EGF indicated that SP-A interferes with EGF binding to EGFR, and a ligand blot analysis suggested that SP-A binds EGFR in A549 cells. We also found that SP-A directly binds the recombinant extracellular domain of EGFR (soluble EGFR or sEGFR), and this binding, unlike that of SP-D, was not blocked by EDTA, excess mannose, or peptide:N-glycosidase F treatment. We prepared a collagenase-resistant fragment (CRF) of SP-A, consisting of CRD plus the neck domain of SP-A, and observed that CRF directly binds sEGFR but does not suppress EGF-induced phosphorylation of EGFR in or proliferation of A549 cells. These results indicated that SP-A binds EGFR and down-regulates EGF signaling by inhibiting ligand binding to EGFR as well as SP-D. However, unlike for SP-D, SP-A lectin activity and EGFR N-glycans were not involved in the interaction between SP-A and EGFR. Furthermore, our results suggested that oligomerization of SP-A is necessary to suppress the effects of SP-A on EGF signaling.
机译:我们最近报道,凝集素表面活性剂蛋白D(SP-D)通过SP-D的碳水化合物识别域(CRD)和N-聚糖之间的相互作用干扰配体与EGFR的结合,从而抑制表皮生长因子受体(EGFR)信号传导。 EGFR。在这里,我们报道表面活性剂蛋白A(SP-A)还抑制了A549人肺腺癌细胞和稳定表达人EGFR的CHOK1细胞中的EGF信号传导,并且SP-A抑制了A549细胞的增殖和运动。 125 I-EGF的结果表明SP-A干扰EGF与EGFR的结合,配体印迹分析表明SP-A与A549细胞中的EGFR结合。我们还发现SP-A直接结合EGFR的重组胞外域(可溶性EGFR或sEGFR),并且与SP-D不同,这种结合并未被EDTA,过量的甘露糖或肽:N-糖苷酶F处理所阻断。我们制备了SP-A的胶原酶抗性片段(CRF),该片段由CRD和SP-A的颈域组成,并观察到CRF直接结合sEGFR,但不抑制EGF诱导的A549细胞中EGFR的磷酸化或增殖。这些结果表明SP-A结合EGFR并通过抑制配体与EGFR以及SP-D的结合而下调EGF信号传导。但是,与SP-D不同,SP-A凝集素活性和EGFR N-聚糖不参与SP-A和EGFR之间的相互作用。此外,我们的结果表明,SP-A的低聚是抑制SP-A对EGF信号传导的影响所必需的。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号